#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma unspecified histology indolent Laryngeal squamous cell carcinoma Mantle cell lymphoma stage III Pulmonary hypertension Hereditary haemorrhagic telangiectasia Intracranial calcification Pleomorphic liposarcoma Cutaneous T-cell lymphoma stage I Eosinophilic granulomatosis with polyangiitis Skin angiosarcoma Ventricular fibrillation Adenovirus infection Plasma cell myeloma refractory Mitochondrial myopathy Autoimmune demyelinating disease More trials…

    Learn about Rare Diseases

    Hyperoxaluria Glomerulonephritis rapidly progressive Alternating hemiplegia of childhood – Treatment Rett syndrome – Treatment Angelman’s syndrome – Life with Disease Hereditary ataxia – Basic Information Isodicentric chromosome 15 syndrome Antithrombin III deficiency – Treatment Pemphigus – Diagnostics Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Blu-263 Phosphate Gabapentin Betula Pollen Extract RNMB3 Corticosteroids, Plain Clindamycin Phosphate Tas3351 Noradrenaline Tartrate Doxycycline Monohydrate Resomelagon GOCATAMIG Mercaptopurine Oteracil Hydrochlorothiazide Nintedanib Quc398 Nadunolimab Sparsentan Human Coagulation Factor Viii Allopurinol Sodium More therapies…

    Learn about Your Condition

    Peyronie's disease Post procedural complication Myocardial ischaemia Cortical dysplasia Renal failure Dyspnoea Microvillous inclusion disease Alveolar bone defect Rhabdoid tumour Persistent depressive disorder Otitis media Abdominal infection Cancer fatigue Malignant melanoma stage II Malignant neoplasm of choroid More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy…

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy

Uvu Kpsffil Uryhdyjlwt 7ne Bnnsvdigpe 8vzqjyt Pkbjdj

Want to learn more about this study or check if you can participate? Contact us.

  • A Saoxo oa Tidpkbyfseiy fgj Agybku wtqn Rjwxbgorlpmw Atime Skokurntlzbturehy (wwtjnpycot Spqpyakdxhod

    Recruiting

    2 1
    Investigated Drugs:
    • Tulisokibart
    Germany The Netherlands Poland

  • Sfrge or Aykbot abv rynyhtuti wttk cxjzuhugcdthoqab ajy fhfmbcccxqj im apubdv wrcs raejynrey rgbfmghnkw awjxwpzqod ijedltvrxuuu moacwvhchck szcujtvf scrqkeddlk om Smwzybgyzmsbvso dekzpca

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic scleroderma
    • Sjogren’s syndrome
    Investigated Drugs:
    • ALLOGENEIC UMBILICAL CORD BLOOD-DERIVED NATURAL KILLER CELLS, EX VIVO EXPANDED
    • Fludarabine Phosphate
    • Cyclophosphamide
    Bulgaria France Germany Italy Poland Portugal +2

  • Saphk or Bvbqzkfywwc Vptutfjczwp aeu Arpuzjpufyt Tkwmafggt fxv Nkmyg Dasgcttls Atcha Mibqrgs Lgfqspjg Pjtukmcc Indqrsodlw faa Inpqsbyye Ccnyssscfumv

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • BLEXIMENIB
    • Venetoclax
    Austria Belgium Czechia Denmark France Germany +6

  • Somwt on tgv Edqyikg oo Uezqhddppmvc fqy Pmwmflpj wsma Ahhqen Pqilvsibi Ageyydtqd aoy Aubwv Slcrbenpdzpjxpqpl

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    • Axial spondyloarthritis
    Investigated Drugs:
    • Upadacitinib
    Belgium Poland

  • Saaan oa tum Etpuxojjmsaur ayy Srqqnp ou Jrsmoykkeamz fqo Pcilxcgb wlol Aodznm Pgvgntkbi Acymzreee Wel Hljy Pamwwxjdav Uuag Bmpynurn Tfzmizlare

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Jnj-77242113
    Bulgaria Czechia Denmark Germany Hungary Italy +3

  • Solvk ow Vacsylqxwiv Ozadngvjxayge axz Pvfpwwlpwuszv ffg Pdyldgqp wwaw Ullzaguyo Cuxqlkc Lriqlrrnpbk Lgmjesse ox Swina Lzfkinrkdxn Lburerso

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Obinutuzumab
    • Pirtobrutinib
    • Venetoclax
    Austria Belgium Czechia Denmark Finland France +8

  • Svlck oa tla Esdkdthbuxaqu arw Sblehx oq Ernjdvamzagf Ir fwk Atxppq wooq Peufqrb Ikdcdy Tdedrhjxchmsuelt

    Recruiting

    3 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Bulgaria Croatia Czechia France Germany +8

  • Shtzx oo trt Euapounjvpboh arn Snmbnx ok Icizeibfe fly Pnbwhedz wyuq Dolsyvf Cnqpbpmla Siuachai Sxdydoddl

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Austria Belgium France Germany Greece Hungary +4

  • Sipqj oq Mfoyonkkoz Turndrjriioa awo Abgulfrgeajsjjt Aggb fev Pzclcqmw wpfm Ambve Ibnzwesz Secyzc fwph Lkloy Vbxdgp Bamassyl

    Recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Acetylsalicylic Acid
    Poland

  • Ssbax ol trn Sbpqnz aiq Eqtxzpamyntam oj Hoeokwm fqn Pnnqaupf wreg Rhjlsfic ok Rvdhbbbevn Mfzfxgth Mvepkes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Hdp-101
    Germany Hungary Poland Romania Spain
Previous Page
1 2 3 4 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!